IGF1R and diffuse large B-cell lymphoma: The latest study has indicated that SMO is involved in the regulation of the oncogenic IGF1R/AKT signaling axis and is unrelated to canonical Hedgehog signaling in diffuse large B-cell lymphoma (DLBCL) (44).